Oryzon Genomics Market Cap

Oryzon Genomics has a market cap or net worth of €232.22 million as of March 2, 2026. Its market cap has increased by 80.33% in one year.

Market Cap

232.22M

Enterprise Value

219.23M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

€2.84

Market Cap Chart

Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 232.22M, an increase of 90.35%. That is a compound annual growth rate of 6.50%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	247.60M	0.96%
Dec 31, 2025	245.23M	170.69%
Dec 31, 2024	90.60M	-16.71%
Dec 29, 2023	108.78M	-18.27%
Dec 30, 2022	133.08M	-6.58%
Dec 30, 2021	142.46M	-32.20%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Grifols	6.47B
Laboratorios Farmaceuticos Rovi	4.33B
Almirall	2.77B
Faes Farma	1.62B
Pharma Mar	1.38B
Clínica Baviera	835.83M
Prim, S.A.	232.27M
Atrys Health	224.59M

Market Cap Rankings